Novartis AG
XMUN:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
XMUN:NOT
|
CH |
|
C
|
Cognex Corp
F:CGZ
|
US |
|
I
|
Installed Building Products Inc
F:2IL
|
US |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 144.75 EUR with a low forecast of 105.51 EUR and a high forecast of 167.22 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
144.75
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 144.75 EUR with a low forecast of 105.51 EUR and a high forecast of 167.22 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for Novartis AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Novartis AG?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.